Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years
Authors
Keywords
-
Journal
BRAIN
Volume 138, Issue 11, Pages 3386-3399
Publisher
Oxford University Press (OUP)
Online
2015-10-26
DOI
10.1093/brain/awv235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The influence of PRNP polymorphisms on human prion disease susceptibility: an update
- (2015) Atsushi Kobayashi et al. ACTA NEUROPATHOLOGICA
- Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
- (2014) Malin K. Sandberg et al. Nature Communications
- Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems
- (2014) Atsushi Kobayashi et al. Acta Neuropathologica Communications
- The Medical Research Council Prion Disease Rating Scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies
- (2013) Andrew G.B. Thompson et al. BRAIN
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
- (2013) Mathias Jucker et al. NATURE
- Prion propagation and toxicity in vivo occur in two distinct mechanistic phases
- (2011) Malin K. Sandberg et al. NATURE
- Diversity of prion diseases: (no) strains attached?
- (2010) Sebastian Brandner ACTA NEUROPATHOLOGICA
- Molecular pathology of human prion disease
- (2010) Jonathan D. F. Wadsworth et al. ACTA NEUROPATHOLOGICA
- Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future
- (2010) Piero Parchi et al. ACTA NEUROPATHOLOGICA
- Review: Contribution of transgenic models to understanding human prion disease
- (2010) J. D. F. Wadsworth et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties
- (2010) M. T. Bishop et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
- (2009) John Collinge et al. LANCET NEUROLOGY
- A Novel Protective Prion Protein Variant that Colocalizes with Kuru Exposure
- (2009) Simon Mead et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the Human Transmission Risk of an Atypical Bovine Spongiform Encephalopathy Prion Strain
- (2008) Q. Kong et al. JOURNAL OF VIROLOGY
- Genetic risk factors for variant Creutzfeldt–Jakob disease: a genome-wide association study
- (2008) Simon Mead et al. LANCET NEUROLOGY
- The origin of the prion agent of kuru: molecular and biological strain typing
- (2008) J. D. F. Wadsworth et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Prominent and Persistent Extraneural Infection in Human PrP Transgenic Mice Infected with Variant CJD
- (2008) Vincent Béringue et al. PLoS One
- Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice
- (2008) J. D. F. Wadsworth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started